All sites C00-96,D32-33,D42-43,D45-47,D76 711 93.1 2.0 2.1 0.5 2.4
Mouth, pharynx C00-14 16 98.7 - 1.3 - -
  Lip C00 2 100.0 - - - -
  Tongue C02 2 100.0 - - - -
  Mouth, other C03-06 5 100.0 - - - -
  Salivary glands C07-08 1 75.0 - 25.0 - -
  Pharynx C01,C09-14 5 100.0 - - - -
Digestive organs C15-26 142 89.8 1.6 4.9 1.1 2.5
  Oesophagus C15 9 93.6 - 2.1 - 4.3
  Stomach C16 15 98.6 - - - 1.4
  Small intestine C17 3 100.0 - - - -
  Colon C18 42 98.1 - 0.9 0.5 0.5
  Rectum, rectosigmoid C19-20 32 98.1 - - 0.6 1.3
  Anus C21 1 100.0 - - - -
  Liver C22 14 80.6 1.4 12.5 1.4 4.2
  Gallbladder, bile ducts C23-24 3 78.6 - 14.3 - 7.1
  Pancreas C25 21 58.5 9.4 19.8 4.7 7.5
  Other digestive organs C26 1 100.0 - - - -
Respiratory organs C30-39 79 83.6 8.6 4.0 0.3 3.5
  Nose, sinuses C30-31 - - - - - -
  Larynx, epiglottis C32 8 100.0 - - - -
  Lung, trachea C33-34 71 82.5 9.6 4.2 0.3 3.4
  Mediastinum, pleura C38 0 - - 100.0 - -
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 28 100.0 - - - -
Skin, non-melanoma C44 40 99.5 0.5 - - -
Mesothelioma C45 3 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 5 87.5 - 8.3 - 4.2
Breast C50 1 100.0 - - - -
Male genital organs C60-63 239 99.7 - - 0.2 0.2
  Prostate C61 233 99.7 - - 0.2 0.2
  Testis C62 3 100.0 - - - -
  Other male genital C60,C63 2 100.0 - - - -
Urinary organs C64-68 67 94.3 0.9 1.5 0.6 2.7
  Kidney C64 21 90.6 - 2.8 - 6.6
  Bladder and urinary tract2 C65-68 46 96.1 1.3 0.9 0.9 0.9
Eye C69 0 50.0 50.0 - - -
Brain, central nervous system C70-72,D32-33,D42-43 17 89.2 - 3.6 - 7.2
Thyroid gland C73 4 100.0 - - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 9 74.5 - 12.8 2.1 10.6
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 59 80.1 7.4 2.0 0.7 9.8
  Hodgkin lymphoma C81 5 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 25 99.2 0.8 - - -
  Malignant immunoproliferative diseases C88 0 50.0 50.0 - - -
  Myeloma and other plasma cell tumors C90 9 56.8 11.4 11.4 2.3 18.2
  Leukaemia C91-95 13 68.7 19.4 1.5 - 10.4
  Myelodysplastic syndromes D46 4 52.4 9.5 - - 38.1
  Myeloproliferaitive neoplasms D45,D47 2 36.4 - - 9.1 54.5
Not included above
  Basal cell carcinoma of the skin 168 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.